CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-12.86%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.17B
AUM Growth
+$1.17B
(-6.1%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
56.5%
Holding
50
New
8
Increased
13
Reduced
9
Closed
4
Top Buys
| 1 |
Viatris
VTRS
|
$60.4M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
$42.2M |
| 3 |
AstraZeneca
AZN
|
$39.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$20.1M |
| 5 |
HMSY
HMS Holdings Corp.
HMSY
|
$19.1M |
Top Sells
| 1 |
Cigna
CI
|
$48.6M |
| 2 |
Masimo
MASI
|
$34.7M |
| 3 |
Dentsply Sirona
XRAY
|
$25.8M |
| 4 |
Perrigo
PRGO
|
$22.7M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$12.1M |
Sector Composition
| 1 | Healthcare | 71.52% |
| 2 | Consumer Staples | 3.62% |
| 3 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $113M | 9.67% | 2,000,000 +250,000 | +14% | +$14.1M |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $94.9M | 8.13% | 2,500,000 | – | – |
|
|
3
AstraZeneca
AZN
$248B
| $79.6M | 6.81% | 2,500,000 +1,250,000 | +100% | +$39.8M |
|
|
CYBX
4
DELISTED
CYBERONICS INC
CYBX
| $60.8M | 5.21% | 1,000,000 | – | – |
|
|
5
Viatris
VTRS
$12.3B
| $60.4M | 5.17% | +1,500,000 | New | +$60.4M |
|
|
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
| $53M | 4.54% | 1,100,000 | – | – |
|
|
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
| $51.8M | 4.44% | 2,450,000 +350,000 | +17% | +$7.41M |
|
8
Orthofix Medical
OFIX
$592M
| $50.6M | 4.34% | 1,500,000 | – | – |
|
|
ESRX
9
DELISTED
Express Scripts Holding Company
ESRX
| $48.6M | 4.16% | 600,000 -150,000 | -20% | -$12.1M |
|
10
Select Medical
SEM
$1.61B
| $46.9M | 4.02% | 4,350,000 +850,000 | +24% | +$9.17M |
|
11
Labcorp
LH
$23.1B
| $43.4M | 3.72% | 400,000 | – | – |
|
|
MJN
12
DELISTED
Mead Johnson Nutrition Company
MJN
| $42.2M | 3.62% | +600,000 | New | +$42.2M |
|
|
UAM
13
DELISTED
Universal American Corp
UAM
| $40.2M | 3.44% | 5,875,000 +640,102 | +12% | +$4.38M |
|
|
14
Masimo
MASI
$7.59B
| $38.6M | 3.3% | 1,000,000 -900,000 | -47% | -$34.7M |
|
|
ARIA
15
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $32.3M | 2.77% | 5,533,118 -216,882 | -4% | -$1.27M |
|
16
Nektar Therapeutics
NKTR
$568M
| $24.7M | 2.11% | 2,250,000 +750,000 | +50% | +$8.22M |
|
|
SQNM
17
DELISTED
SEQUENOM INC NEW
SQNM
| $20.6M | 1.76% | 11,750,000 +2,750,000 | +31% | +$4.81M |
|
18
Cross Country Healthcare
CCRN
$438M
| $20.3M | 1.74% | 1,493,765 | – | – |
|
|
19
Alnylam Pharmaceuticals
ALNY
$58.5B
| $20.1M | 1.72% | +250,000 | New | +$20.1M |
|
|
HMSY
20
DELISTED
HMS Holdings Corp.
HMSY
| $19.1M | 1.64% | +2,179,900 | New | +$19.1M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $18.6M | 1.6% | 9,750,000 +2,250,000 | +30% | +$4.3M |
|
22
Tenet Healthcare
THC
$16.3B
| $18.5M | 1.58% | +500,000 | New | +$18.5M |
|
|
KND
23
DELISTED
Kindred Healthcare
KND
| $17.3M | 1.48% | 1,100,000 | – | – |
|
24
Quest Diagnostics
DGX
$20.3B
| $13.4M | 1.15% | 218,500 -31,500 | -13% | -$1.94M |
|
|
AMRN
25
Amarin Corp
AMRN
$311M
| $12.5M | 1.07% | 6,500,000 -3,500,000 | -35% | -$6.76M |
|